Skip to main content
. 2024 May 29;13(6):503. doi: 10.3390/antibiotics13060503
ADR Adverse drug reactions
CNS Central nervous system
DDIs Drug–drug interactions
DOAC Direct oral anticoagulants
EPIC III Extended Study on Prevalence of Infection in Intensive Care III
ICU Intensive care units
IV Intravenously
MAO Monoamine oxidase
MRSA Methicillin-resistant Staphylococcus aureus
PD Pharmacodynamic
PK Pharmacokinetic
UGT UDP-glucuronosyltransferase
RRT Renal replacement therapy
VPA Valproic acid